Tag Archives: Exclusive

Biopharma, Limited Distribution Drugs, Rare/Orphan Disease, Specialty Drug, Specialty Pharmacy

Biologics by McKesson Selected as Exclusive Pharmacy Partner for Sentynl Therapeutics’ ZOKINVY

Posted on by John Santilli

Biologics by McKesson Selected as Exclusive Specialty Pharmacy Partner for Sentynl Therapeutics’ FDA approved ZOKINVY

Continue reading →
Biopharma, Biosimilar, Limited Distribution Drugs, Specialty Drug, Specialty HUBs, Specialty Pharmacy

Biologics Selected as Exclusive Specialty Pharmacy Provider for CAMCEVI

Posted on by John Santilli

Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Accord BioPharma, Inc. as an exclusive specialty pharmacy provider for CAMCEVI 

Continue reading →
Biopharma, Limited Distribution Drugs, Rare/Orphan Disease, Specialty Pharmacy

Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy and Anovo as Exclusive Specialty Pharmacies

Posted on by John Santilli

Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy and Anovo as Exclusive Specialty Pharmacies for ORMALVI and Tiopronin

Continue reading →
Rare/Orphan Disease, Specialty Pharmacy

PANTHERx Selected by UCB as Exclusive Specialty Pharmacy for ZILBRYSQ

Posted on by John Santilli

Zilbrysq is available through the specialty pharmacy PANTHERx Rare Pharmacy and through a Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious meningococcal infections.

Continue reading →